Emileigh R. Binet

Emileigh R. Binet

Auto-generated profile, based on publicly available information

Emileigh R. Binet

Department of Kinesiology, McMaster University, Hamilton, ON, Canada

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2022 in American Journal of Physiology-Cell Physiology
Verified
Journal Article
Closed access
PDF file
NCNicolas Collao
Nicolas Collao
PAPaul Akohene-Mensah
Paul Akohene-Mensah
JNJulian Nallabelli
Julian Nallabelli
EBEmileigh R. Binet
Emileigh R. Binet
AAAli Askarian
Ali Askarian
MLMichael De Lisio
Michael De Lisio
Satellite cells are required for muscle regeneration, remodeling, and repair through their activation, proliferation, and differentiation; however, how dietary factors regulate this process remains poorly understood. The L-type amino acid transporter 1 (LAT1) transports amino acids, such as leucine, into mature myofibers, which then stimulate protein synthesis and anabolic signaling. However, whether LAT1 is expressed on myoblasts and is involved in regulating myogenesis is unknown. The aim of this study was to characterize the expressional and functional relevance of LAT1 during different stages of myogenesis and in response to growth and atrophic conditions in vitro. We determined that LAT1 is expressed by C2C12 and human primary myoblasts, and its gene expression is lower during differentiation (P < 0.05). Pharmacological inhibition and genetic knockdown of LAT1 impaired myoblast viability, differentiation, and fusion (all P < 0.05). LAT1 protein content in C2C12 myoblasts was not significantly altered in response to different leucine concentrations in cell culture media or in two in vitro atrophy models. However, LAT1 content was decreased in myotubes under atrophic conditions in vitro (P < 0.05). These findings indicate that LAT1 is stable throughout myogenesis and in response to several in vitro conditions that induce muscle remodeling. Further, amino acid transport through LAT1 is required for normal myogenesis in vitro.

1 January 2023 in Journal of Applied Physiology
Verified
Journal Article
Closed access
PDF file
EBEmileigh R. Binet
Emileigh R. Binet
CMColleen F. McKenna
Colleen F. McKenna
ASAmadeo F. Salvador
Amadeo F. Salvador
IMIsabel G. Martinez
Isabel G. Martinez
RARafael A. Alamilla
Rafael A. Alamilla
MLMichael De Lisio
Michael De Lisio
Resistance training combined with adequate protein intake supports skeletal muscle strength and hypertrophy. These adaptations are supported by the action of muscle stem cells (MuSCs) which are regulated, in part, by fibro-adipogenic progenitors (FAPs) and circulating factors delivered through capillaries. It is unclear if middle-aged males and females have similar adaptations to resistance training at the cellular level. To address this gap, 27 (13 males, 14 females) middle-aged (40-64 years) adults participated in 10-weeks of whole-body resistance training with dietary counselling. Muscle biopsies were collected from the vastus lateralis pre- and post-training. Type II fibre cross-sectional area increased similarly with training in both sexes (P = 0.014). MuSC content was not altered with training; however, training increased PDGFRα+/CD90+ FAP content (P < 0.0001) and reduced PDGFRα+/CD90- FAP content (P = 0.044), independent of sex. The number of CD31+ capillaries per fibre also increased similarly in both sexes (p<0.05). These results suggest that muscle fibre hypertrophy, stem/progenitor cell, and capillary adaptations are similar between middle-aged males and females in response to whole-body resistance training.

29 August 2025 in Scandinavian Journal of Medicine & Science in Sports
Verified
Journal Article
Open access
JRJohn R. Matthew Renwick
John R. Matthew Renwick
JCJeff Crukley
Jeff Crukley
MKMasa Kudsi
Masa Kudsi
EBEmileigh R. Binet
Emileigh R. Binet
JBJack Bone
Jack Bone
MGMartin J. Gibala
Martin J. Gibala
Low‐volume sprint interval training (LVSIT) increases peak oxygen uptake (VO2peak) when performed three times a week for 6 weeks. Methodological and statistical concerns, however, constrain the veracity of prior findings. We therefore reassessed the VO2peak response to LVSIT using a randomized controlled trial design to mitigate bias and augment reporting quality. A generative model of VO2peak was constructed as a function of group, baseline VO2peak, age, sex, height, and change in body mass. Simulation experiments using previous data estimated that n = 15/group would achieve 80% power to detect a difference of 1 metabolic equivalent (MET) with a credible interval (CrI) of ≤ 1‐MET. Insufficiently active young adults (22 ± 3 years, body mass index: 24 ± 4 kg m−2, baseline VO2peak: 33 ± 7 mL kg−1 min−1) were randomized to perform 6 weeks of thrice weekly LVSIT (n = 17) or no exercise (CTL; n = 20). The LVSIT protocol involved 3 × 20‐s “all out” sprints over a 10‐min session of low‐intensity cycling. Bayesian generative multivariate modeling revealed that LVSIT increased absolute [+325 mL min−1 (101–605)] and relative VO2peak [+5.6 mL kg−1 min−1 (2.2–8.1)] versus CTL. All but one LVSIT participant (94%) were deemed a responder (i.e., mean estimate ± 95% CrI for relative VO2peak > 0). In contrast, four CTL participants (20%) met this criterion. LVSIT also improved time to exhaustion by +133 s (101–160) versus CTL. We unequivocally demonstrate that 6 weeks of thrice weekly LVSIT increased VO2peak in insufficiently active young adults compared to no exercise. By incorporating a robust design that included preregistration, concealed allocation assignment, statistical best practices, and applied Bayesian methods, and open data‐sharing, this study addresses prior methodological critiques of similar previous work.

1 September 2025 in International Journal of Sport Nutrition and Exercise Metabolism
Verified
Journal Article
Closed access
PDF file
ACAlexandra M. Coates
Alexandra M. Coates
DPDhriti V. Patel
Dhriti V. Patel
EBEmileigh R. Binet
Emileigh R. Binet
MGMartin J. Gibala
Martin J. Gibala
Oral magnesium supplementation can reduce muscle soreness and muscle damage markers after unaccustomed exercise. However, the effectiveness of topical magnesium applications remains unclear. This randomized, double-blind, parallel-design study investigated whether a commercial magnesium gel could reduce the perception of muscle soreness and muscle damage markers following an acute bout of unaccustomed exercise. Healthy active participants ( n = 35) performed a 40-min bout of downhill treadmill running. Magnesium (Mg) or placebo (Pla) gels were administered to each thigh 10 min before and immediately after exercise. Measurements were made before (Pre) and immediately (Post), 24 hr, and 48 hr after exercise. The primary outcome was muscle soreness using a 0–100 visual analog scale after a sit-to-stand maneuver. Secondary outcomes included peak isometric knee extensor strength, plasma creatine kinase, and serum interleukin-6. There were no differences between treatments on any outcome. Compared with Pre (Mg: 4 ± 5, Pla: 4 ± 5 a.u.), muscle soreness was higher post (Mg: 28 ± 20, Pla: 21 ± 14) and after 24 hr (Mg: 43 ± 27, Pla: 41 ± 26) and 48 hr (Mg: 42 ± 31, Pla: 32 ± 23) (all main effects, p < .0001). Interleukin-6 was higher Post (Mg: 1.8 ± 0.7, Pla: 1.6 ± 0.7 pg/ml) versus Pre (Mg: 1.1 ± 0.8, Pla: 1.1 ± 0.6; main effect, p = .006), and creatine kinase was higher Post (Mg: 111 ± 57, Pla: 121 ± 44 U/L), 24 hr (Mg: 216 ± 113, Pla: 228 ± 97), and 48 hr (Mg: 136 ± 45, Pla: 179 ± 85) versus Pre (Mg: 93 ± 54, Pla: 91 ± 30; all main effects, p < .001). Knee extensor strength was reduced after exercise (main effect, p = .04). The Mg gel did not reduce muscle soreness or muscle damage markers after unaccustomed exercise compared with Pla. The dose (0.53 mg/ml) or application protocol may have been insufficient to elicit a meaningful effect.